Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Could CT radiomics be the new frontier for myocardial tissue characterisation in cardiomyopathies?

Raman B. and Clarke N., (2025), Eur Heart J Cardiovasc Imaging

Assessing the impact of COmorbidities and Sociodemographic factors on Multiorgan Injury following COVID-19: rationale and protocol design of COSMIC, a UK multicentre observational study of COVID-negative controls.

Shergill S. et al, (2025), BMJ Open, 15

Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.

Gharibzadeh S. et al, (2025), EClinicalMedicine, 79

1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID

Finnigan LEM. et al, (2024), Radiology, 313

1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID.

Finnigan LEM. et al, (2024), Radiology, 313

Diagnostic utility of electrocardiogram for screening of cardiac injury on cardiac magnetic resonance in post-hospitalised COVID-19 patients: a prospective multicenter study.

Samat AHA. et al, (2024), Int J Cardiol, 415

Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19: A Prospective, Multicenter, Cohort Study.

Shiwani H. et al, (2024), JACC Cardiovasc Imaging, 17, 1320 - 1331

Feasibility of multiorgan risk prediction with routinely collected diagnostics: a prospective cohort study in the UK Biobank.

McCracken C. et al, (2024), BMJ Evid Based Med, 29, 313 - 323

1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study.

Leavy OC. et al, (2024), ERJ Open Res, 10

Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.

Taquet M. et al, (2024), Lancet Psychiatry, 11, 696 - 708

Flow inefficiencies in non-obstructive HCM revealed by kinetic energy and hemodynamic forces on 4D-flow CMR.

Pola K. et al, (2024), Eur Heart J Imaging Methods Pract, 2

Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVID.

Elneima O. et al, (2024), ERJ Open Res, 10

Photon-counting computed tomography: 'one-stop shop' for coronary stenosis, inflammation, and myocardial assessment in ST-segment elevation acute coronary syndrome.

Kotronias RA. et al, (2024), Eur Heart J Cardiovasc Imaging, 25

Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy.

Maron MS. et al, (2024), J Am Coll Cardiol, 83, 2037 - 2048

Long COVID and cardiovascular disease: a prospective cohort study.

Lawson CA. et al, (2024), Open Heart, 11

The complexity of cardiovascular long COVID: where we are.

Gandhi RS. and Raman B., (2024), Cardiovasc Res

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.

Coleman JA. et al, (2024), Cardiovascular research, cvae086 - cvae086

Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study.

Elneima O. et al, (2024), Int J Epidemiol, 53

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.

C-MORE/PHOSP-COVID Collaborative Group None., (2023), Lancet Respir Med, 11, 1003 - 1019

Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis.

Dawson C. et al, (2023), BMJ Open Respir Res, 10

Load More

Include forthcoming?